Complete Blood Count (CBC) Test Overview

The complete blood count (CBC) is a common blood test that measures the different cells in your blood, including red blood cells, white blood cells, and platelets, and helps your doctor evaluate your overall health and screen for many conditions.

The 1-methylhistidine test measures the amount of 1-methylhistidine in amniotic fluid. 1-Methylhistidine is a compound produced when the body metabolizes certain amino acids, particularly from muscle tissue. This test is part of prenatal screening that helps healthcare providers assess fetal health and development.

A healthcare professional will draw a small sample of blood from a vein in your arm, usually on the inside of your elbow, using a thin needle. The procedure takes only a few minutes, and you can return to your normal activities right afterward.

During amniocentesis, a healthcare provider uses ultrasound guidance to insert a thin needle through the abdomen and into the uterus to collect a small sample of amniotic fluid. The sample is then sent to a laboratory where the level of 1-methylhistidine is measured. This procedure is typically performed between 15-20 weeks of pregnancy, though timing may vary based on clinical needs.

This test is important because it helps detect a wide range of conditions, such as anemia, infections, and blood disorders, often before symptoms appear, allowing your doctor to diagnose problems early and plan the most appropriate treatment for you.

Measuring 1-methylhistidine in amniotic fluid can provide important information about fetal metabolism. Abnormal levels may suggest certain genetic metabolic disorders or issues with fetal muscle development. This information helps healthcare providers make informed decisions about pregnancy management and prepare for any necessary interventions after birth.